Section Arrow
NUWE.NASDAQ
- Nuwellis Inc
Quotes are at least 15-min delayed:2026/08/06 11:35 EDT
Regular Hours
Last
 1.74
+0.03 (+1.75%)
Day High 
1.8 
Prev. Close
1.71 
1-M High
6.3999 
Volume 
208.85K 
Bid
1.7
Ask
1.75
Day Low
1.6209 
Open
1.7 
1-M Low
1.3449 
Market Cap 
622.94K 
Currency 美元 
P/E 0.04 
%Yield -- 
10-SMA 2.15 
20-SMA 2.55 
50-SMA 6.68 
52-W High 235.2 
52-W Low 1.3449 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
47.25/-0.04
Enterprise Value
689.94K
Balance Sheet
Book Value Per Share
7.30
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.27M
Operating Revenue Per Share
23.75
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PACBPacific Biosciences of California1.2199-0.0801-6.16%-- 
BSXBoston Scientific Corp50.055+2.315+4.85%19.69PE
ABTAbbott Laboratories106.44+0.73+0.69%34.21PE
AHCOAdaptHealth Corp6.38-0.115-1.77%-- 
AMIXAutonomix Medical Inc.11.45-0.65-5.37%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.